These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 18957017)

  • 1. [Immunosuppressive treatment in patients starting peritoneal dialysis after functional arrest of kidney transplant. What to do?].
    Pérez Fontán M; Rodríguez-Carmona A
    Nefrologia; 2008; 28 Suppl 6():83-6. PubMed ID: 18957017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Peritoneal dialysis after renal graft loss: against maintenance of immunosuppression].
    Pérez Contreras J
    Nefrologia; 2008; 28 Suppl 6():87-96. PubMed ID: 18957018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcomes after failed renal transplantation-does dialysis modality matter?
    Perl J; Bargman JM; Davies SJ; Jassal SV
    Semin Dial; 2008; 21(3):239-44. PubMed ID: 18533967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dialysis after kidney transplant failure: do patients start in a worse condition than the general population with chronic kidney disease?
    Caldés Ruisánchez S; Marcén Letosa R; Amezquita Orjuela Y; Fernández Lucas M; Rivera Gorrin M; Galeano Álvarez C; Fernández Rodríguez A; Teruel Briones JL; Quereda Rodríguez-Navarro C
    Nefrologia; 2011; 31(1):51-7. PubMed ID: 21270913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continued transplant immunosuppression may prolong survival after return to peritoneal dialysis: results of a decision analysis.
    Jassal SV; Lok CE; Walele A; Bargman JM
    Am J Kidney Dis; 2002 Jul; 40(1):178-83. PubMed ID: 12087576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of residual renal function loss in peritoneal dialysis: is previous renal transplantation a risk factor?
    Bernardo A; Fonseca I; Rodrigues A; Carvalho MJ; Cabrita A
    Adv Perit Dial; 2009; 25():110-4. PubMed ID: 19886330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peritoneal dialysis in transplant recipient patients: outcomes and management.
    Faria B; Rodrigues A
    Scand J Urol Nephrol; 2011 Dec; 45(6):444-51. PubMed ID: 21702728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent peritoneal dialysis catheter exit-site leak in a patient receiving maintenance immunosuppression with sirolimus.
    Perl J; Jassal SV; Bargman JM
    Clin Transplant; 2008; 22(5):672-3. PubMed ID: 18435788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluating renal function and indications for starting dialysis].
    Teruel JL; Torrente J; Fernández Lucas M; Marcén R; González Parra E; Zarraga S; García G
    Nefrologia; 2009; 29 Suppl 1():38-43. PubMed ID: 19675660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Patients in pre-dialysis: decision taking and free choice of treatment].
    Sarrias Lorenz X; Bardón Otero E; Vila Paz ML
    Nefrologia; 2008; 28 Suppl 3():119-22. PubMed ID: 19018749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of dialysis modality on complications and patient and graft survival after pancreas-kidney transplantation.
    Jiménez C; Manrique A; Morales JM; Andrés A; Ortuño T; Abradelo M; Gimeno A; Calvo J; Cambra F; Sterup RL; Moreno E
    Transplant Proc; 2008 Nov; 40(9):2999-3000. PubMed ID: 19010172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of dialysis duration and modality on kidney transplant outcomes.
    Resende L; Guerra J; Santana A; Mil-Homens C; Abreu F; da Costa AG
    Transplant Proc; 2009 Apr; 41(3):837-9. PubMed ID: 19376365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preemptive living-donor renal transplantation: outcome and clinical advantages.
    Yoo SW; Kwon OJ; Kang CM
    Transplant Proc; 2009; 41(1):117-20. PubMed ID: 19249492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adequacy of peritoneal dialysis and the importance of preserving residual renal function.
    van den Wall Bake AW; Kooman JP; Lange JM; Smit W
    Nephrol Dial Transplant; 2006 Jul; 21 Suppl 2():ii34-7. PubMed ID: 16825258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Peritoneal dialysis in cirrhotic patients].
    De Vecchi AF
    G Ital Nefrol; 2009; 26(2):215-24. PubMed ID: 19382077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resolved: in minimizing kidney transplant immunosuppression, steroids should go before calcineurin inhibitors: pro.
    Matas AJ
    J Am Soc Nephrol; 2007 Dec; 18(12):3026-8. PubMed ID: 18003783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Residual renal function and volume status in peritoneal dialysis patients: a conflict of interest?
    Van Biesen W; Lameire N; Verbeke F; Vanholder R
    J Nephrol; 2008; 21(3):299-304. PubMed ID: 18587717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Residual renal function in children treated with continuous ambulatory peritoneal dialysis or automated peritoneal dialysis--a preliminary study.
    Roszkowska-Blaim M; Skrzypczyk P; Drozdz D; Pietrzyk JA
    Adv Perit Dial; 2009; 25():103-9. PubMed ID: 19886329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Post-transplant diabetes mellitus depending on the pre-transplant dialysis technique].
    Bayés B; Moreso F; Benítez R; Torres A; Díaz JM; Granada ML; Lauzurica R; Pastor MC; Teixidó J
    Nefrologia; 2008; 28 Suppl 6():97-102. PubMed ID: 18957019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.